Alnylam bids adieu to 2020 — and hello to a slate of new execs; Novavax taps Rick Crowley as COO
→ John Maraganore is closing out the year with a surge of new hires at Alnylam just a month after lumasiran notched an FDA approval for primary hyperoxaluria type 1 (PH1). Tolga Tanguler, who takes on the role of chief commercial officer, has Big Pharma experience at Pfizer, tackling multiple positions and rising to president of their North America rare disease unit. For the last 2 years, Tanguler was SVP and head of US for Alexion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.